news Iceni Pharmaceuticals launches to repurpose cancer therapies 25 May 2016 | By Victoria White, Digital Content Producer The company’s lead product Cilcane (generic name cilengitide) is being repurposed by Iceni as a first-in-class treatment for multiple myeloma...